Using this cis-activation strategy in primary cells and muscle, we have demonstrated an increase in transgene expression of more than 600-fold from a minimal simian virus 40 (SV40) promoter and an ...

The outbreak of Ebola virus in West Africa in 2014-16 killed more than 11,000 people. Vaccination is vital for disease control. A recombinant Ebola virus vaccine, jointly developed by Beijing ...

Recommendations announced for influenza vaccine composition for the 2025–2026 northern hemisphere influenza season - The ...

Janet Mertz’s work with simian virus 40 DNA during her graduate years was pivotal for developing DNA recombination as we now know it. Berg was awarded one-half of the Nobel Prize in Chemistry in 1980 ...

The Recombinant Protein Production and Characterization (RPPC) Core is an Institutional Advanced Technology Core available to all Baylor College of Medicine investigators on a fee-for-service basis.

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Vimkunya™, a recombinant chikungunya vaccine, ...

The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...